Growth Hormone Deficiency
Total Payments
$457,327
Transactions
7
Doctors
0
Companies
1
Payment Trends by Year
| Year | Amount | Transactions | Doctors |
|---|---|---|---|
| 2019 | $457,327 | 7 | 0 |
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Unspecified | $457,327 | 7 | 100.0% |
Research Studies & Clinical Trials
| Study Name | Sponsor | Amount | Doctors |
|---|---|---|---|
| A Clinical Study Investigating the Comparability of Somatrogon in Two Different Drug Product Presentations | OPKO Pharmaceuticals, LLC | $457,327 | 0 |
Top Doctors Receiving Payments for Growth Hormone Deficiency
| Doctor | Specialty | Location | Total | Records |
|---|---|---|---|---|
| Unknown | — | Newark, DE | $457,327 | 7 |
Ad
Manufacturing Companies
- OPKO Pharmaceuticals, LLC $457,327
Product Information
- Type Drug
- Total Payments $457,327
- Total Doctors 0
- Transactions 7
About Growth Hormone Deficiency
Growth Hormone Deficiency is a drug associated with $457,327 in payments to 0 healthcare providers, recorded across 7 transactions in the CMS Open Payments database. The primary manufacturer is OPKO Pharmaceuticals, LLC.
Payment data is available from 2019 to 2019. In 2019, $457,327 was paid across 7 transactions to 0 doctors.
The most common payment nature for Growth Hormone Deficiency is "Unspecified" ($457,327, 100.0% of total).
Growth Hormone Deficiency is associated with 1 research study, including "A Clinical Study Investigating the Comparability of Somatrogon in Two Different Drug Product Presentations" ($457,327).